BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23956362)

  • 21. Extended duration infusion of high-dose hydroxocobalamin for vasoplegic syndrome following cardiac surgery.
    Seelhammer TG; Plack D; Nei S; Wittwer E; Nelson J; Nabzdyk CGS
    Heart Lung; 2021; 50(2):173-176. PubMed ID: 33242823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pro: methylene blue as a rescue therapy for vasoplegia after cardiac surgery.
    Riha H; Augoustides JG
    J Cardiothorac Vasc Anesth; 2011 Aug; 25(4):736-8. PubMed ID: 21684764
    [No Abstract]   [Full Text] [Related]  

  • 23. Vasoresponsiveness in patients with heart failure (VASOR): protocol for a prospective observational study.
    van Vessem ME; Beeres SLMA; de Wilde RBP; de Vries R; Berendsen RR; de Jonge E; Danser AHJ; Klautz RJM; Schalij MJ; Palmen M
    J Cardiothorac Surg; 2019 Nov; 14(1):200. PubMed ID: 31752946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. eComment: No change in B-type natriuretic peptide levels assessed in the intermediate postoperative period in patients with severe mitral regurgitation after mitral valve surgery.
    Bockeria LA; Nikitina T; Gulyan K; Grabskaya E
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):771. PubMed ID: 21555442
    [No Abstract]   [Full Text] [Related]  

  • 25. [Methylene blue therapy for vasoplegia after cardiac surgery].
    Skuza K; Chmielniak S; Dziuk W; Kucewicz E; Pawlak S; Knapik P
    Anestezjol Intens Ter; 2009; 41(3):159-62. PubMed ID: 19999604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. eComment. Resident surgical training in mitral valve surgery.
    Garcia-Villarreal OA
    Interact Cardiovasc Thorac Surg; 2016 Nov; 23(5):813. PubMed ID: 27880709
    [No Abstract]   [Full Text] [Related]  

  • 27. Risk factors for vasoplegia after coronary artery bypass and valve surgery.
    Bastopcu M; Sargın M; Kuplay H; Erdoğan SB; Yapıcı N; Aka SA
    J Card Surg; 2021 Aug; 36(8):2729-2734. PubMed ID: 34018257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The additional use of methylene blue has a decatecholaminisation effect on cardiac vasoplegic syndrome after cardiac surgery.
    Petermichl W; Gruber M; Schoeller I; Allouch K; Graf BM; Zausig YA
    J Cardiothorac Surg; 2021 Jul; 16(1):205. PubMed ID: 34321019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxocobalamin With or Without Methylene Blue May Improve Fluid Balance in Critically Ill Patients With Vasoplegic Syndrome After Cardiac Surgery: A Report of Two Cases.
    Zundel MT; Feih JT; Rinka JRG; Boettcher BT; Freed JK; Kaiser M; Ghadiali HY; Tawil JN; Woehlck HJ; Pagel PS
    J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):452-457. PubMed ID: 28778773
    [No Abstract]   [Full Text] [Related]  

  • 30. Angiotensin II and Vasoplegia in Cardiac Surgery: Paradigm Changer or Costly Contender?
    Chow JH; Strauss E; Mazzeffi MA
    J Cardiothorac Vasc Anesth; 2021 Jan; 35(1):59-60. PubMed ID: 32950345
    [No Abstract]   [Full Text] [Related]  

  • 31. [Vasoplegic syndrome after cardiac surgery with cardiopulmonary bypass].
    Lehot JJ
    Ann Fr Anesth Reanim; 2012 May; 31 Suppl 1():S18-21. PubMed ID: 22721515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasoplegic syndrome during Whipple procedure.
    Anandaswamy TC; Rajappa GC; Krishnamachar H
    J Clin Anesth; 2017 Feb; 36():151-152. PubMed ID: 28183555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Con: methylene blue should not be used routinely for vasoplegia perioperatively.
    Andritsos MJ
    J Cardiothorac Vasc Anesth; 2011 Aug; 25(4):739-43. PubMed ID: 21684763
    [No Abstract]   [Full Text] [Related]  

  • 34. Risk factors for vasoplegia after cardiac surgery: a meta-analysis.
    Dayan V; Cal R; Giangrossi F
    Interact Cardiovasc Thorac Surg; 2019 Jun; 28(6):838-844. PubMed ID: 30649312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. eComment: Should triangular resection be an adequate approach for prolapsing posterior leaflet in all types of degenerative mitral valve disease?
    Bockeria LA; Skopin II; Tsiskaridze IM
    Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):290. PubMed ID: 19628542
    [No Abstract]   [Full Text] [Related]  

  • 36. Power for the Sickest: Vitamin C for Vasoplegia after Cardiac Surgery.
    Long MT; Hess AS; McCarthy DP; DeCamp MM
    J Cardiothorac Vasc Anesth; 2020 Apr; 34(4):1123. PubMed ID: 31623966
    [No Abstract]   [Full Text] [Related]  

  • 37. Methylene Blue: Magic Bullet for Vasoplegia?
    Hosseinian L; Weiner M; Levin MA; Fischer GW
    Anesth Analg; 2016 Jan; 122(1):194-201. PubMed ID: 26678471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraoperative vasoplegia: methylene blue to the rescue!
    McCartney SL; Duce L; Ghadimi K
    Curr Opin Anaesthesiol; 2018 Feb; 31(1):43-49. PubMed ID: 29176374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Commentary: Is angiotensin II a game changer for vasoplegia after cardiac surgery, or is the jury still out?
    Chatterjee S
    J Thorac Cardiovasc Surg; 2022 Apr; 163(4):1415-1416. PubMed ID: 33888313
    [No Abstract]   [Full Text] [Related]  

  • 40. Longer term hemodialysis-dependent chronic renal failure increases the risk of post-cardiac surgery vasoplegic syndrome.
    Suga M; Kawakami D; Ueta H; Shimozono T; Ito J; Seo R; Nakamori Y; Korenaga A; Morimoto T; Mima H
    J Anesth; 2020 Apr; 34(2):243-249. PubMed ID: 31900585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.